These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32558420)

  • 21. Pre-existing elevated pulmonary vascular resistance: long-term hemodynamic follow-up and outcome of recipients after orthotopic heart transplantation.
    Tenderich G; Koerner MM; Stuettgen B; Mirow N; Arusoglu L; Morshuis M; Bairaktaris A; Minami K; Koerfer R
    J Cardiovasc Surg (Torino); 2000 Apr; 41(2):215-9. PubMed ID: 10901524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Markers of pulmonary hypertension in potential candidates to heart transplantation.
    Wierzbicki K; Przybyłowski P; Sobczyk D; Konstanty J; Kapelak B; Drwiła R; Krochin M; Podolec P; Wójcik S; Marek G; Wróbel K; Piatek J; Rudziński P; Sadowski J
    Przegl Lek; 2006; 63(12):1263-8. PubMed ID: 17642136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents.
    Murali S; Uretsky BF; Reddy PS; Tokarczyk TR; Betschart AR
    Am Heart J; 1991 Nov; 122(5):1375-81. PubMed ID: 1951003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bosentan in heart transplantation candidates with severe pulmonary hypertension: efficacy, safety and outcome after transplantation.
    Perez-Villa F; Farrero M; Cardona M; Castel MA; Tatjer I; Penela D; Vallejos I
    Clin Transplant; 2013; 27(1):25-31. PubMed ID: 22861120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of sildenafil in heart transplant recipients with pulmonary hypertension may prevent right heart failure.
    Maruszewski M; Zakliczyński M; Przybylski R; Kucewicz-Czech E; Zembala M
    Transplant Proc; 2007 Nov; 39(9):2850-2. PubMed ID: 18021999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversible pulmonary hypertension in heart transplant candidates--pretransplant evaluation and outcome after orthotopic heart transplantation.
    Klotz S; Deng MC; Hanafy D; Schmid C; Stypmann J; Schmidt C; Hammel D; Scheld HH
    Eur J Heart Fail; 2003 Oct; 5(5):645-53. PubMed ID: 14607204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamics of patients developing pulmonary arterial hypertension after shunt closure.
    D'Alto M; Romeo E; Argiento P; Correra A; Santoro G; Gaio G; Sarubbi B; Calabrò R; Russo MG
    Int J Cardiol; 2013 Oct; 168(4):3797-801. PubMed ID: 23850317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of continuous-flow ventricular assist device therapy with intensive medical therapy in fixed pulmonary hypertension secondary to advanced left heart failure.
    Kumarasinghe G; Jain P; Jabbour A; Lai J; Keogh AM; Kotlyar E; Jansz P; Macdonald PS; Hayward CS
    ESC Heart Fail; 2018 Aug; 5(4):695-702. PubMed ID: 29573567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.
    Braun S; Schrötter H; Schmeisser A; Strasser RH
    Int J Cardiol; 2007 Jan; 115(1):67-72. PubMed ID: 16797747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates.
    Radovancevic B; Vrtovec B; Thomas CD; Croitoru M; Myers TJ; Radovancevic R; Khan T; Massin EK; Frazier OH
    J Heart Lung Transplant; 2005 Jun; 24(6):690-5. PubMed ID: 15949728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of severe combined post- and pre-capillary pulmonary hypertension in a patient with idiopathic restrictive cardiomyopathy.
    Ishihara S; Kioka H; Ohtani T; Asano Y; Yamaguchi O; Hikoso S; Toda K; Saito Y; Sawa Y; Yamauchi-Takihara K; Sakata Y
    Pulm Circ; 2018; 8(3):2045894018770131. PubMed ID: 29575985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the transpulmonary pressure gradient a predictor for mortality after orthotopic cardiac transplantation?
    Gorlitzer M; Ankersmit J; Fiegl N; Meinhart J; Lanzenberger M; Unal K; Dunkler D; Kilo J; Wolner E; Grimm M; Grabenwoeger M
    Transpl Int; 2005 Apr; 18(4):390-5. PubMed ID: 15773956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of a cutoff value on echo Doppler analysis to replace right heart catheterization during pulmonary hypertension evaluation in heart transplant candidates.
    Bacal F; de Freitas AF; Moreira LF; Fiorelli AI; Mangini S; Abuhab A; de Lima Oliveira J; Santos RH; Stolf NA; Bocchi EA
    Transplant Proc; 2010 Mar; 42(2):535-8. PubMed ID: 20304186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance.
    Sablotzki A; Hentschel T; Gruenig E; Schubert S; Friedrich I; Mühling J; Dehne MG; Czeslick E
    Eur J Cardiothorac Surg; 2002 Nov; 22(5):746-52. PubMed ID: 12414041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency.
    Adamson RM; Dembitsky WP; Jaski BE; Daily PO; Moreno R; Kim JC; Sono J; Akasaka T; Hoagland PM; Gordon JB
    ASAIO J; 1997; 43(4):365-9. PubMed ID: 9242955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease.
    Limsuwan A; Khosithseth A; Wanichkul S; Khowsathit P
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):98-104. PubMed ID: 19089967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The hemodynamics of the lesser circulation before and after heart transplantation in patients with dilated cardiomyopathy].
    Shumakov VI; Kormer AIa; Kozakov EN; Chestukhin VV; Shemakin SIu
    Grud Serdechnososudistaia Khir; 1993; (6):4-7. PubMed ID: 8312006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is high risk? Redefining elevated pulmonary vascular resistance index in pediatric heart transplantation.
    Chiu P; Russo MJ; Davies RR; Addonizio LJ; Richmond ME; Chen JM
    J Heart Lung Transplant; 2012 Jan; 31(1):61-6. PubMed ID: 22019236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern of resolution of pulmonary hypertension, long-term allograft right ventricular function, and exercise capacity in high-risk heart transplant recipients listed under oral sildenafil.
    De Santo LS; Buonocore M; Agrusta F; Bancone C; Galdieri N; Romano G; Maiello C; Amarelli C
    Clin Transplant; 2014 Jul; 28(7):837-43. PubMed ID: 24828060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Impact of pulmonary hypertension on early hemodynamics after orthotopic heart transplantation].
    Liu MZ; Wang JH; Du J; Huang J; Li LH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2618-22. PubMed ID: 18162149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.